119 related articles for article (PubMed ID: 21710494)
41. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
Rao GS; Hanjani P
Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
[TBL] [Abstract][Full Text] [Related]
42. Detection of serum autoantibodies to tumor suppressor gene p53 with a new enzyme-linked immunosorbent assay in patients with ovarian cancer.
Marx D; Frey M; Zentgraf H; Adelssen G; Schauer A; Kuhn W; Meden H
Cancer Detect Prev; 2001; 25(2):117-22. PubMed ID: 11341346
[TBL] [Abstract][Full Text] [Related]
43. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
44. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
[TBL] [Abstract][Full Text] [Related]
45. Sterol regulatory element-binding protein 1 is required for ovarian tumor growth.
Nie LY; Lu QT; Li WH; Yang N; Dongol S; Zhang X; Jiang J
Oncol Rep; 2013 Sep; 30(3):1346-54. PubMed ID: 23818099
[TBL] [Abstract][Full Text] [Related]
46. The expression of interleukin-10 in patients with primary ovarian epithelial carcinoma and in ovarian carcinoma cell lines.
Zhou J; Ye F; Chen H; Lv W; Gan N
J Int Med Res; 2007; 35(3):290-300. PubMed ID: 17593856
[TBL] [Abstract][Full Text] [Related]
47. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
48. Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.
Chinni SR; Falchetto R; Gercel-Taylor C; Shabanowitz J; Hunt DF; Taylor DD
Clin Cancer Res; 1997 Sep; 3(9):1557-64. PubMed ID: 9815843
[TBL] [Abstract][Full Text] [Related]
49. [Soluble interleukin-2 receptor level in the sera and ascitic fluids in patients with ovarian cancer].
Pu FR; Cheng SW; Zhu D
Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):478-80, 511. PubMed ID: 7835120
[TBL] [Abstract][Full Text] [Related]
50. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.
Mills GB; May C; Hill M; Campbell S; Shaw P; Marks A
J Clin Invest; 1990 Sep; 86(3):851-5. PubMed ID: 2394835
[TBL] [Abstract][Full Text] [Related]
51. The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma.
Yigit S; Demir L; Tarhan MO; Cabuk FK; Ellidokuz H; Erten C; Somali I; Dirican A; Cakalagaoglu F
Neoplasma; 2012; 59(5):475-85. PubMed ID: 22668011
[TBL] [Abstract][Full Text] [Related]
52. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
[TBL] [Abstract][Full Text] [Related]
53. Increased levels of laminin in ascitic fluid of patients with ovarian cancer.
Byers LJ; Osborne JL; Carson LF; Carter JR; Haney AF; Weinberg JB; Ramakrishnan S
Cancer Lett; 1995 Jan; 88(1):67-72. PubMed ID: 7850775
[TBL] [Abstract][Full Text] [Related]
54. Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response.
Carbone A; Rodeck U; Mauri FA; Sozzi M; Gaspari F; Smirne C; Prati A; Addeo A; Novarino A; Robecchi A; Bertetto O; Emanuelli G; Bellone G
Cancer Biol Ther; 2005 Feb; 4(2):231-41. PubMed ID: 15684607
[TBL] [Abstract][Full Text] [Related]
55. Identification and characterization of a Kunitz-type protease inhibitor in ascites fluid from patients with ovarian carcinoma.
Kobayashi H; Hirashima Y; Sun GW; Ohi H; Fujie M; Terao T
Int J Cancer; 2000 Jul; 87(1):44-54. PubMed ID: 10861451
[TBL] [Abstract][Full Text] [Related]
56. Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies.
Da Gama Duarte J; Quigley LT; Young AR; Hayashi M; Miyazawa M; Lopata A; Mancuso N; Mikami M; Behren A; Meeusen E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681879
[TBL] [Abstract][Full Text] [Related]
57. Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer.
Santin AD; Bellone S; Ravaggi A; Roman J; Smith CV; Pecorelli S; Cannon MJ; Parham GP
BJOG; 2001 Aug; 108(8):804-8. PubMed ID: 11510703
[TBL] [Abstract][Full Text] [Related]
58. Spontaneous release of interleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human ovarian carcinoma.
Burger RA; Grosen EA; Ioli GR; Van Eden ME; Park M; Berman ML; Manetta A; Disaia PJ; Granger GA; Gatanaga T
J Interferon Cytokine Res; 1995 Mar; 15(3):255-60. PubMed ID: 7584672
[TBL] [Abstract][Full Text] [Related]
59. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer.
Gastl G; Plante M; Finstad CL; Wong GY; Federici MG; Bander NH; Rubin SC
Br J Haematol; 1993 Mar; 83(3):433-41. PubMed ID: 8485049
[TBL] [Abstract][Full Text] [Related]
60. Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapy.
Lavoué V; Cabillic F; Toutirais O; Thedrez A; Dessarthe B; de La Pintière CT; Daniel P; Foucher F; Bauville E; Henno S; Burtin F; Bansard JY; Levêque J; Catros V; Bouet-Toussaint F
Int J Cancer; 2012 Aug; 131(4):E449-62. PubMed ID: 22095289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
